Home | Privacy | Contact    

Information About Ovarian Cancer


Ovarian cancer - Wikipedia, the free encyclopedia
http://en.wikipedia.org/wiki/Ovarian_cancer Ovarian cancer is a cancerous growth arising from the ovary. Symptoms are frequently very subtle early on and may include: bloating, pelvic pain, difficulty eating ... more...
Ovarian Cancer Symptoms, Signs, Prognosis, Stages, Treatment ...
http://www.medicinenet.com/ovarian_cancer/article.htm Get information on ovarian cancer symptoms, signs, prognosis, staging, treatment, diagnosis, screening tests, research, and risk factors. Treatment options include ... more...
Ovarian Cancer Home Page - National Cancer Institute
http://www.cancer.gov/cancertopics/types/ovarian/ Information about ovarian cancer treatment, prevention, genetics, causes, screening, clinical trials, research and statistics from the National Cancer Institute. more...
Ovarian Cancer Center: Symptoms, Treatments, Prognosis, Stages ...
http://www.webmd.com/ovarian-cancer/default.htm Ovarian cancer is diagnosed in an estimated 20,000 women in the U.S. each year. Find in-depth ovarian cancer information here including its diagnosis, symptoms, and ... more...
Ovarian cancer - MayoClinic.com - Mayo Clinic
http://www.mayoclinic.com/health/ovarian-cancer/DS00293 Ovarian cancer — Comprehensive overview covers ovarian cancer symptoms, diagnosis, treatment and future treatments. more...



Ovarian Cancer News


ovarian cancer - Bing News
IMPORTANT: Bing News RSS feed has moved!
Go to the new RSS page and renew your subscription.
read more...
RedCannon Security, Inc. and
FREMONT, Calif. and NEW YORK, May 9, 2012 /PRNewswire-iReach/-- RedCannon Security, Inc. announced today  that together with   read more...
Rexahn Pharmaceuticals Submits Archexin Phase II Protocol for
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase II protocol for the ... read more...

read more...
Targeting
Dr. Robert Bristow believes a decidedly low-tech approach could significantly enhance the survival rate for read more...